Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal vs Sublingual Misoprostol for Second Trimester Intrauterine Fetal Death
NCT00141895Phase 3Terminated
- Sponsor
- American University of Beirut Medical Center
- Start
- Sep 2004
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol in intrauterine fetal demise (IUFD) (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Induction time at 48 hours. Started Sep 2004; status: terminated.
02
Drugs
misoprostol
03
Conditions
intrauterine fetal demise (IUFD)
Beyond the preview
Go deeper on NCT00141895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141895.